ATPW
XENE icon

Ashton Thomas Private Wealth’s Xenon Pharmaceuticals XENE Stock Holding History

Ashton Thomas Private Wealth’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-135
Closed -$5.26K – 1869
2024
Q2 		$5.26K Buy
+135
New +$5.4K ﹤0.01% 1540

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Ashton Thomas Private Wealth's XENE Position: Q3 2024 in Review

Ashton Thomas Private Wealth sold out of Xenon Pharmaceuticals (XENE) in Q3 2024, closing a stake of 135 shares — an estimated $5.26K sold.

Ashton Thomas Private Wealth first reported a position in XENE in Q2 2024 and held it in 1 quarter. The position peaked at $5.26K in Q2 2024. 203 funds tracked by Wall St. Rank hold XENE as of Q3 2024.

  • Ashton Thomas Private Wealth reported no remaining Xenon Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Ashton Thomas Private Wealth sold 135 Xenon Pharmaceuticals shares in Q3 2024, an estimated $5.26K.
  • Ashton Thomas Private Wealth first reported a position in Xenon Pharmaceuticals in Q2 2024 and held it in 1 quarter.
  • Ashton Thomas Private Wealth's Xenon Pharmaceuticals position peaked at $5.26K in Q2 2024.
  • 203 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2024.

Based on Ashton Thomas Private Wealth's 13F filing for Q3 2024, filed 5 Nov 2024.